Tradestie Institutional Equity Comparison Engine
VIVS vs PRLB โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PRLB Overall Edge
PRLB Captures Institutional Edge (4โ0 Pillars ยท 10โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Proto Labs, Inc. (PRLB) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, VIVS trades at N/M Forward P/E with -10117.0% operating margin (-51.4% YoY revenue) versus PRLB at 25.0x Forward P/E and 8.1% operating margin (+14.0% YoY). In options structure, VIVS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against PRLB sits in CONSOLIDATION (9th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
PRLB
VIVS N/M vs PRLB 25.0x Fwd P/E
Growth & Margin Winner
PRLB
Op Margin -10117.0% vs 8.1% ยท YoY -51.4% vs +14.0%
Momentum & Technical Winner
PRLB
1Y -87.0% vs +33.4% ยท 52W Pos 5% vs 31%
Options & Structure Winner
PRLB
BREAKDOWN (N/A IV) vs CONSOLIDATION (9th %ile IV)
VIVS
NASDAQ
VivoSim Labs, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.29
+142.92% 1D
Market Cap
$2.4M
1M Return
+64.69%
1Y Return
-86.99%
Forward P/E
N/M
Unified AI Score
36.8 / 100
SELL
Tech 5.0
Fund 38.0
Flow 50.0
Mom 50.0
PRLB
NYSE
Proto Labs, Inc.
Fabricated Structural Metal Products
$62.89
-1.57% 1D
Market Cap
$1.5B
1M Return
-29.88%
1Y Return
+33.35%
Forward P/E
25.0x
Unified AI Score
62.1 / 100
BUY
Tech 78.0
Fund 69.0
Flow 54.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
VIVS -86.99%
PRLB +33.35%
Spread: +120.34 pp (PRLB Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | VIVS Revenue | PRLB Revenue | VIVS Op. Margin | PRLB Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $0M | $460M | -882.4% | 17.4% | PRLB |
| FY2020 | $0M | $430M | -977.9% | 13.8% | PRLB |
| FY2021 | N/A | $490M | N/A | 8.3% | PRLB |
| FY2022 | $0M | $490M | -765.3% | -20.1% | PRLB |
| FY2023 | $0M | $500M | -4792.2% | 5.6% | PRLB |
| FY2024 | $0M | $500M | -13840.4% | 4.0% | PRLB |
| FY2025 | $0M | $530M | -8761.1% | 4.7% | PRLB |
| FY2026 | $0M | N/A | -8768.7% | N/A | VIVS |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VIVS | PRLB | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.4M | $1.5B | Larger Scale | PRLB |
| Trailing P/E Ratio Valuation | N/M | 43.8x | Lower Multiple | PRLB |
| Forward P/E Ratio Valuation | N/M | 25.0x | Lower Multiple | PRLB |
| Revenue Growth (YoY) Growth | -51.4% | +14.0% | Higher Growth | PRLB |
| Operating Margin (TTM) Profitability | -10117.0% | 8.1% | Higher Margin | PRLB |
| Net Profit Margin Profitability | 0.0% | 6.0% | Higher Margin | PRLB |
| Return on Equity (ROE) Capital Efficiency | -343.1% | 5.1% | Higher ROE | PRLB |
| 52-Week Range Position Momentum | 5% ($0โ$3) | 31% ($46โ$100) | Stronger Trend | PRLB |
| Beta / 30D Volatility Risk Regime | 0.83ฮฒ ยท 480% Vol | 1.85ฮฒ ยท 75% Vol | Lower Realized Risk | PRLB |
| Unified Institutional Score Composite Signal | 36.8 / 100 (SELL) | 62.1 / 100 (BUY) | Higher Composite | PRLB |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full VIVS vs PRLB Buy Guide
VIVS
BREAKDOWN
73d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
PRLB
CONSOLIDATION
106d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
9th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither VIVS nor PRLB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.